InTrack Investment Management Inc trimmed its position in shares of The Procter & Gamble Company (NYSE:PG - Free Report) by 24.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 9,723 shares of the company's stock after selling 3,097 shares during the period. Procter & Gamble accounts for approximately 1.5% of InTrack Investment Management Inc's portfolio, making the stock its 19th largest holding. InTrack Investment Management Inc's holdings in Procter & Gamble were worth $1,657,000 at the end of the most recent reporting period.
A number of other large investors have also bought and sold shares of PG. NewSquare Capital LLC boosted its holdings in Procter & Gamble by 933.3% in the 4th quarter. NewSquare Capital LLC now owns 155 shares of the company's stock valued at $26,000 after purchasing an additional 140 shares during the period. Navigoe LLC bought a new stake in Procter & Gamble during the fourth quarter valued at $31,000. Capital A Wealth Management LLC bought a new stake in Procter & Gamble during the fourth quarter valued at $31,000. Hoey Investments Inc. grew its position in Procter & Gamble by 321.7% during the fourth quarter. Hoey Investments Inc. now owns 194 shares of the company's stock worth $33,000 after buying an additional 148 shares in the last quarter. Finally, LFA Lugano Financial Advisors SA bought a new position in Procter & Gamble in the 4th quarter worth about $34,000. 65.77% of the stock is owned by hedge funds and other institutional investors.
Procter & Gamble Trading Down 1.9%
Procter & Gamble stock traded down $3.12 during mid-day trading on Friday, reaching $160.06. 7,093,816 shares of the company traded hands, compared to its average volume of 7,357,593. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.76 and a quick ratio of 0.55. The Procter & Gamble Company has a 52-week low of $156.58 and a 52-week high of $180.43. The firm has a market capitalization of $375.27 billion, a price-to-earnings ratio of 25.49, a P/E/G ratio of 3.76 and a beta of 0.43. The firm's 50 day moving average price is $163.70 and its 200 day moving average price is $166.95.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its earnings results on Thursday, April 24th. The company reported $1.54 earnings per share for the quarter, topping analysts' consensus estimates of $1.53 by $0.01. The firm had revenue of $19.78 billion for the quarter, compared to the consensus estimate of $20.42 billion. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. The business's revenue for the quarter was down 2.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.52 EPS. On average, analysts anticipate that The Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Monday, April 21st were paid a dividend of $1.0568 per share. This is an increase from Procter & Gamble's previous quarterly dividend of $1.01. The ex-dividend date of this dividend was Monday, April 21st. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.64%. Procter & Gamble's dividend payout ratio (DPR) is currently 66.98%.
Analyst Upgrades and Downgrades
Several brokerages have recently commented on PG. Morgan Stanley set a $180.00 price objective on Procter & Gamble and gave the stock an "overweight" rating in a report on Friday, April 25th. Barclays reissued an "equal weight" rating on shares of Procter & Gamble in a report on Thursday, March 27th. Raymond James cut their target price on shares of Procter & Gamble from $190.00 to $185.00 and set an "outperform" rating for the company in a research report on Friday, April 25th. Truist Financial dropped their price target on Procter & Gamble from $185.00 to $180.00 and set a "buy" rating for the company in a research note on Friday, April 25th. Finally, Citigroup cut their price objective on Procter & Gamble from $200.00 to $181.00 and set a "buy" rating for the company in a report on Friday, April 25th. Eight research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, Procter & Gamble presently has a consensus rating of "Moderate Buy" and a consensus target price of $178.86.
Get Our Latest Stock Analysis on Procter & Gamble
Insider Activity
In related news, CEO Jennifer L. Davis sold 1,000 shares of Procter & Gamble stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total value of $161,380.00. Following the completion of the sale, the chief executive officer now directly owns 51,965 shares in the company, valued at approximately $8,386,111.70. This trade represents a 1.89% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Moses Victor Javier Aguilar sold 10,520 shares of the firm's stock in a transaction on Monday, May 5th. The stock was sold at an average price of $158.67, for a total value of $1,669,208.40. Following the completion of the transaction, the insider now directly owns 25,182 shares in the company, valued at approximately $3,995,627.94. This represents a 29.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.18% of the company's stock.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.